Sands Capital Management, LLC Repligen Corp Transaction History

Sands Capital Management, LLC

  • $34.1 Billion
  • Q1 2024

A detailed history of Sands Capital Management, LLC transactions in Repligen Corp stock. As of the latest transaction made, Sands Capital Management, LLC holds 1,432,737 shares of RGEN stock, worth $214 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares
1,432,737
Previous 1,495,337 4.19%
Holding current value
$214 Million
Previous $269 Million 1.99%
% of portfolio
0.77%
Previous 0.85%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$170.78 - $208.42 $10.7 Million - $13 Million
-62,600 Reduced 4.19%
1,432,737 $264 Million
Q4 2023

Feb 13, 2024
SELL
$114.17 - $185.35 $8.57 Million - $13.9 Million
-75,026 Reduced 4.78%
1,495,337 $269 Million
Q3 2023

Nov 14, 2023
SELL
$138.78 - $176.51 $3.31 Million - $4.2 Million
-23,816 Reduced 1.49%
1,570,363 $250 Million
Q2 2023

Aug 15, 2023
SELL
$138.42 - $180.31 $2.86 Million - $3.73 Million
-20,672 Reduced 1.28%
1,594,179 $226 Million
Q1 2023

May 12, 2023
SELL
$154.26 - $198.1 $25.7 Million - $33 Million
-166,588 Reduced 9.35%
1,614,851 $272 Million
Q4 2022

Feb 13, 2023
BUY
$162.42 - $220.56 $23.1 Million - $31.4 Million
142,480 Added 8.69%
1,781,439 $302 Million
Q3 2022

Nov 09, 2022
BUY
$160.42 - $256.21 $263 Million - $420 Million
1,638,959 New
1,638,959 $307 Million

Others Institutions Holding RGEN

# of Institutions
522
Shares Held
53.2M
Call Options Held
1.05M
Put Options Held
228K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.27B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Sands Capital Management, LLC Portfolio

Follow Sands Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sands Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sands Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email